Regional impairment of mucociliary clearance in chronic obstructive pulmonary disease. 1993

G C Smaldone, and W M Foster, and T G O'Riordan, and M S Messina, and R J Perry, and E G Langenback
Department of Medicine, State University of New York, Stony Brook 11794-8172.

Asthmatic subjects with tidal expiratory flow limitation have mucociliary clearance (MC) impairment in central airways. Because tidal flow limitation develops in COPD, it is possible that regional MC in these patients also may be affected. We tested this hypothesis by measuring MC in the presence or absence of flow limitations. Patients with COPD and chronic flow limitation were compared with non-flow-limited normal volunteers. Deposition was normalized for regional lung volume and expressed as the specific central to peripheral (sC/P) ratio. In COPD subjects, clearance from the whole lung and central airways was significantly different from that of normal subjects after 20 min of observation. In the peripheral airways, there were no significant differences between COPD and normal subjects. An alternative analysis of regional MC indicated patients retained particles in central airways while normal subjects, with intact MC, emptied central airways. Thus, COPD subjects with tidal expiratory flow limitation have impaired MC in their central airways.

UI MeSH Term Description Entries
D008173 Lung Diseases, Obstructive Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent. Obstructive Lung Diseases,Obstructive Pulmonary Diseases,Lung Disease, Obstructive,Obstructive Lung Disease,Obstructive Pulmonary Disease,Pulmonary Disease, Obstructive,Pulmonary Diseases, Obstructive
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009079 Mucociliary Clearance A non-specific host defense mechanism that removes MUCUS and other material from the LUNGS by ciliary and secretory activity of the tracheobronchial submucosal glands. It is measured in vivo as mucus transfer, ciliary beat frequency, and clearance of radioactive tracers. Mucociliary Transport,Clearance, Mucociliary,Clearances, Mucociliary,Mucociliary Clearances,Mucociliary Transports,Transport, Mucociliary,Transports, Mucociliary
D012123 Pulmonary Ventilation The total volume of gas inspired or expired per unit of time, usually measured in liters per minute. Respiratory Airflow,Ventilation Tests,Ventilation, Pulmonary,Expiratory Airflow,Airflow, Expiratory,Airflow, Respiratory,Test, Ventilation,Tests, Ventilation,Ventilation Test
D005541 Forced Expiratory Volume Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity. Forced Vital Capacity, Timed,Timed Vital Capacity,Vital Capacity, Timed,FEVt,Capacities, Timed Vital,Capacity, Timed Vital,Expiratory Volume, Forced,Expiratory Volumes, Forced,Forced Expiratory Volumes,Timed Vital Capacities,Vital Capacities, Timed,Volume, Forced Expiratory,Volumes, Forced Expiratory
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000336 Aerosols Colloids with a gaseous dispersing phase and either liquid (fog) or solid (smoke) dispersed phase; used in fumigation or in inhalation therapy; may contain propellant agents. Aerosol
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

G C Smaldone, and W M Foster, and T G O'Riordan, and M S Messina, and R J Perry, and E G Langenback
April 2009, Respiratory medicine,
G C Smaldone, and W M Foster, and T G O'Riordan, and M S Messina, and R J Perry, and E G Langenback
October 2011, Rhinology,
G C Smaldone, and W M Foster, and T G O'Riordan, and M S Messina, and R J Perry, and E G Langenback
December 2020, Journal of aerosol medicine and pulmonary drug delivery,
G C Smaldone, and W M Foster, and T G O'Riordan, and M S Messina, and R J Perry, and E G Langenback
March 1998, Respiratory medicine,
G C Smaldone, and W M Foster, and T G O'Riordan, and M S Messina, and R J Perry, and E G Langenback
May 1986, Praxis und Klinik der Pneumologie,
G C Smaldone, and W M Foster, and T G O'Riordan, and M S Messina, and R J Perry, and E G Langenback
May 1988, Annals of nuclear medicine,
G C Smaldone, and W M Foster, and T G O'Riordan, and M S Messina, and R J Perry, and E G Langenback
May 1982, Lancet (London, England),
G C Smaldone, and W M Foster, and T G O'Riordan, and M S Messina, and R J Perry, and E G Langenback
January 1982, Lancet (London, England),
G C Smaldone, and W M Foster, and T G O'Riordan, and M S Messina, and R J Perry, and E G Langenback
August 2019, Journal of aerosol medicine and pulmonary drug delivery,
G C Smaldone, and W M Foster, and T G O'Riordan, and M S Messina, and R J Perry, and E G Langenback
March 1984, Clinics in chest medicine,
Copied contents to your clipboard!